olmesartan medoxomil/amlodipine/hydrochlorothiazide clonmel 40 mg/5 mg/12.5 mg film-coated tablets
clonmel healthcare ltd - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/5 mg/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide
olmesartan medoxomil/amlodipine/hydrochlorothiazide clonmel 40 mg/5 mg/25 mg film-coated tablets
clonmel healthcare ltd - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/5 mg/25 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide
olmesartan medoxomil/amlodipine/hydrochlorothiazide krka 40 mg/10 mg/25 mg film-coated tablets
krka, d.d., novo mesto - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40/10/25 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide
olmesartan medoxomil/amlodipine/hydrochlorothiazide krka 40 mg/5 mg/12.5 mg film-coated tablets
krka, d.d., novo mesto - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40/5/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide
olmesartan medoxomil/amlodipine/hydrochlorothiazide krka 40 mg/5 mg/25 mg film-coated tablets
krka, d.d., novo mesto - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40/5/25 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide
olmesartan medoxomil/amlodipine/hydrochlorothiazide krka 20 mg/5 mg/12.5 mg film-coated tablets
krka, d.d., novo mesto - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 20/5/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide
olmesartan medoxomil/amlodipine/hydrochlorothiazide krka 40 mg/10 mg/12.5 mg film-coated tablets
krka, d.d., novo mesto - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40/10/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide
olmesartan
organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; purified talc - olmesartan-myl is indicated for the treatment of hypertension.
olmesartan
organon pharma pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; purified talc - olmesartan-myl is indicated for the treatment of hypertension.
olmesartan medoxomil and hydrochlorothiazide- olmesartan medoxomil and hydrochlorothiazide 20/12.5 tablet olmesartan medoxomil
torrent pharmaceuticals limited - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - olmesartan medoxomil 20 mg - olmesartan medoxomil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. olmesartan medoxomil and hydrochlorothiazide tablets are not indicated for the initial therapy of hypertension [see dosage and administration (2)] . lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals